# A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.

> **NCT00806260** · PHASE2 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 80 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** VI-0521
- **DRUG:** Placebo
- **OTHER:** Alcohol
- **OTHER:** alcohol placebo

## Key facts

- **NCT ID:** NCT00806260
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806260, "A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00806260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*